Company
Atea Pharmaceuticals, Inc. (AVIR)
Standardized SEC financial data for Atea Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001593899 · NASDAQ · Pharmaceutical Preparations.
Operating margin
-51.5%
Net margin
-45.1%
Revenue growth (YoY)
622.5%
Return on equity
-57.5%
Free cash flow
-$134.0M
Current ratio
7.82×
EPS (diluted)
$-1.94
Ratios for fiscal year 2021, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $48.6M | $351.4M | — | — | — | — |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $850.2M | $764.7M | $646.7M | $578.1M | $454.7M | $301.8M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $296.7M | -$87.0M | -$121.0M | -$85.4M | -$135.5M | -$132.0M |
| Capital expenditures |
Get AVIR data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/AVIR/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/AVIR/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"